Moreover, these recent studies pointed to plasma p-Tau181 and other hyperphosphorylated Tau (p-Tau231, p-Tau217) as the most sensitive plasma biomarkers for AD diagnosis [18,19], even in the early stages [20,21]. Here, MAPT is linked to Alzheimer disease.